The Chemours CC 深 滬
已收盤 08-07 16:00:00 美东时间
15.75
+0.640
+4.24%
華盛通- 最 高16.23
- 今 開15.41
- 成交量 287.30万股
- 最 低 15.34
- 昨 收 15.11
- 總市值 23.70亿
- 52周最高 28.5825
- 市盈率 靜 --
- 換手率 1.91%
- 52周最低 10.265
- 委 比 66.56%
- 總股本 1.50亿
- 歷史最高 50.5225
- 量 比 0.62
- 振 幅 5.89%
- 歷史最低 -4.7075
- 每 手 1
- 風險率 4.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多U.S. court approves New Jersey PFAS settlements totaling $2.5B
A federal judge on Friday approved more than $2.5B of settlements reached by the state of New Jersey with DuPont (DD), 3M (MMM), Chemours (CC), and Corteva (CTVA) to resolve claims over pollution att...
08-08 06:11
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
Truist Securities Maintains Buy on Chemours, Lowers Price Target to $24
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $30 to $24.
08-07 00:10
期权扫描 | 英伟达连涨五日！多张Call单升逾200%；AMD热门Call单押注超跌反弹
英伟达连涨五日创近两个月新高！多张Call单升逾200%；AMD绩后重挫逾7%，热门Call单押注股价超跌反弹>>
08-06 19:37
财报速睇 | The Chemours 2026财年Q2营收15.91亿美元，同比下降1.5%；归母净利润亏损2.74亿美元，同比亏损缩窄27.9%
华盛资讯8月5日讯，The Chemours公布2026财年Q2业绩，公司Q2营收15.91亿美元，同比下降1.5%，归母净利润亏损2.74亿美元，同比亏损缩窄27.9%。
08-05 23:18
Chemours declares $0.0875 dividend
Chemours (CC) declares $0.0875/share quarterly dividend, in line with previous. Forward yield 1.95% Payable Sept. 15; for shareholders of record Aug. 14; ex-div Aug. 14. See CC Dividend Scorecard, Yie...
08-05 10:52
财报速睇 | The Chemours 2026财年Q2营收15.91亿美元，同比下降1.5%；归母净利润亏损2.74亿美元，同比亏损缩窄27.9%
华盛资讯8月5日讯，The Chemours公布2026财年Q2业绩，公司Q2营收15.91亿美元，同比下降1.5%，归母净利润亏损2.74亿美元，同比亏损缩窄27.9%。
08-05 05:16
Chemours shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, the company issued Q3 sales guidance below estimates.
Chemours shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, the company issued Q3 sales guidance below estimates.
08-05 05:03
Chemours Widens FY2026 Sales Guidance from $5.982B-$6.098B to $5.866B-$6.098B vs $6.044B Est
Chemours (NYSE:CC) widens FY2026 sales outlook from $5.982 billion-$6.098 billion to $5.866 billion-$6.098 billion vs $6.044 billion estimate.
08-05 04:40
